Additionally, kallistatin, TAS, TOS, OSI, and TNF-α levels were significantly different in COPD patients compared to the control group during both exacerbation and stable periods (p < 0.001 for each parameter). The gene discussed is TNF; the disease is chronic obstructive pulmonary disease.